mechanism 2,984 words KG: synaptic_loss
Contents

Synaptic Loss in Alzheimer's Disease Pathway

Mechanism Info
Namesynaptic_loss
Key Genes/ProteinsAPOE4 fragments, C1q, soluble_tau_oligomers, SPP1
Related Diseasesalzheimers, Alzheimer's_disease, Cognitive decline, phagocytosis
Related Pathwayscomplement_cascade
Linked Hypotheses1 hypotheses

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (55)

APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74
APOE-TREM2 Interaction Modulation
Score: 0.74
APOE Isoform Conversion Therapy
Score: 0.72
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.71
Mitochondrial Transfer Pathway Enhancement
Score: 0.70
Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.69
Mitochondrial RNA Granule Rescue Pathway
Score: 0.66
FOXO3-Longevity Pathway Epigenetic Reprogramming
Score: 0.63
Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics
Score: 0.62
TREM2-Dependent Microglial Senescence Transition
Score: 0.62
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.58
Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption
Score: 0.47
...
Score: 0.68
APOE-Mediated Synaptic Lipid Raft Stabilization
Score: 0.65
Complement-Mediated Synaptic Pruning Dysregulation
Score: 0.61
← Prevpg 3/3

Related Analyses (30)

SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived

Related Experiments (30)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.90
Brain Connectivity-Targeted tACS Trial in Early AD
clinical · proposed · Score: 0.51
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.45
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.45

See Also (15)

ASL Perfusion Biomarkers for Alzheimer's Disease
biomarker · Pages share 18 hypotheses
Astrocyte-Derived Exosomal mRNA Reference Genes for Alz
biomarker · Pages share 18 hypotheses
AT(N) Biomarker Classification for Alzheimer's Disease
biomarker · Pages share 18 hypotheses
A/T/N+ Comprehensive Biomarker Panel for Alzheimer's Di
biomarker · Pages share 18 hypotheses
Blood p-Tau217 as a Clock for Alzheimer's Disease Onset
mechanism · Pages share 18 hypotheses

Knowledge Graph (12 edges)

phagocytosis causes synaptic_loss
mechanisms-synaptic-loss-ad describes synaptic_loss
tripartite_synapse_dysfunction causes synaptic_loss
complement_cascade causes synaptic_loss
Alzheimer's_disease causes synaptic_loss
tripartite_synapse_dysfunction NULL synaptic_loss
synaptic_loss associated_with alzheimers
synaptic_loss causes Cognitive decline
synaptic_loss associated_with Cognitive decline
soluble_tau_oligomers causes synaptic_loss

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.